| August 7, 2008 |
InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625 |
| August 6, 2008 |
InNexus Biotechnology Announces Third Antibody and Expands Pipeline of Anticancer Compounds |
| July 31, 2008 |
InNexus To Present at 2008 DDT Aug 6th in Boston |
| June 23, 2008 |
InNexus Biotechnology Announces Completion of Brokered Private Placement |
| June 12, 2008 |
InNexus Biotechnology Announces Expansion of Patent Protection of DXL™ Technology |
| June 2, 2008 |
InNexus Biotechnology Launches Competitive Summer Intern Program: LABapprentice |
| May 30, 2008 |
InNexus Biotechnology Announces Oversubscription of Private Placement Raised to $5 Million and Additional Equity Financing up to $7.5 Million |
| May 23, 2008 |
InNexus Biotechnology Announces Brokered Private Placement with Dundee Securities Corporation |
| May 12, 2008 |
InNexus Biotechnology CEO and Scientific Advisory Board Chairman to Present at Global HealthCare and Financial Conferences |
| May 8, 2008 |
InNexus Biotechnology Hosts Inaugural Event of U.S. Department of Commerce |
| May 7, 2008 |
InNexus Biotechnology Receives 2008 Frost & Sullivan Innovation of the Year Award |
| May 7, 2008 |
InNexus Biotechnology Launches Competitive Summer Intern Program -- LABapprentice |
| April 15, 2008 |
InNexus Biotechnology Presents Proof of Principle Data at AACR |
| April 02, 2008 |
InNexus Biotechnology to Present Data at AACR |
| March 31, 2008 |
InNexus Biotechnology Article in March issue of Drug Development News |
| March 21, 2008 |
InNexus Biotechnology Holds Annual General Meeting and Receives Overwhelming Mandate from Shareholders |
| March 14, 2008 |
InNexus Biotechnology Engages Dundee Securities Corporation as Strategic Financial Advisor |
| March 12, 2008 |
InNexus Biotechnology Announces Genetically Engineered DXLmouse™ Platform |
| February 28, 2008 |
InNexus Biotechnology Develops Diagnostics Business Based on DXL™ Technology |
| February 27, 2008 |
InNexus Biotechnology Inc. Announces Earnings for the Second Quarter Ended December 31, 2007 |
| February 19, 2008 |
InNexus Biotechnology Announces Second Preclinical Candidate DXL702 (HER2/neu) Targeting Breast Cancer. Will Host Scientific Teleconference to Discuss latest Product and Progress of DXL™ Pipeline |
| February 11, 2008 |
CEO Jeff Morhet featured in Arizona State University W.P. Carey school of business article - 30JAN2008 |
| February 11, 2008 |
InNexus Biotechnology Welcomes Dr. Ronald Levy, Stanford University School of Medicine Oncology Division Chief to Scientific Advisory Board |
| February 07, 2008 |
ROYALTY PHARMA AND INNEXUS BIOTECHNOLOGY ANNOUNCE AGREEMENT REGARDING THE PURCHASE OF A SECOND ROYALTY RIGHT BASED ON INNEXUS’ DXL™ ANTIBODY TECHNOLOGY |
| February 07, 2008 |
InNexus Biotechnology Announces Preliminary Results of Animal Study Comparing Cancer Killing Activity of Its DXL625 (CD20) Treatment for Non-Hodgkin’s Lymphoma With Leading Marketed Product |
| January 30, 2008 |
InNexus’ CEO to Present at the 6th Annual BioPartnering North America Conference |
| January 29, 2008 |
Three Leading Pharmaceutical Trade Publications Highlight InNexus’ Proprietary Technology, Dynamic Cross Linking |
| January 23, 2008 |
InNexus Board Members Leroy Chiao and Glenn Williamson Featured In National Print Publications |
| January 22, 2008 |
InNexus Highlighted in two leading Pharmaceutical Trade Publications |
| January 22, 2008 |
Oncology News International article with CEO Jeff Morhet |
| January 22, 2008 |
Pharma Voice article with CEO Jeff Morhet |
| January 22, 2008 |
InNexus Biotechnology Announces Dr. Capra Has Joined its Board of Directors |
| December 13, 2007 |
Dr. Maurizio Zanetti joins InNexus Biotechnology Scientific Advisory Board |
| December 11, 2007 |
Dr. Judith James joins InNexus Biotechnology Scientific Advisory Board |
| November 06, 2007 |
InNexus Biotechnology Hosts Company Operational Update Teleconference |
| November 1, 2007 |
InNexus Biotechnology CEO To Present At Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference November 5, 2007 In New York City |
| October 03, 2007 |
InNexus CEO to Present at the 15th Anniversary BioPartnering Europe Conference |
| September 21, 2007 |
InNexus Biotechnology Hosts Open House and On-Site Technology Demonstration |
| September 18, 2007 |
InNexus Biotechnology CEO Scheduled as Guest Speaker on Canada's BNN - Business News Network Channel |
| September 17, 2007 |
InNexus Biotechnology CEO to Give Keynote Presentation at 18th Annual Wall Street Analyst Forum |
| August 9, 2007 |
Innexus Biotechnology To Host Teleconference/Web Cast Outlining Recently Launched Pre-Clinical Candidate DXL625™ (CD20) |
| August 7, 2007 |
InNexus Biotechnology Unveils New Platform For Augmenting Antibody Therapeutics |
| August 2, 2007 |
InNexus Biotechnology to present at 12th Annual Drug Discovery & Development of Innovative Therapeutics World Conference |
| August 1, 2007 |
InNexus Appoints FDA Expert Dr. Jur Strobos To Chief Medical Officer |
| July 27, 2007 |
InNexus Biotechnology Retains the Investor Relations Group of New York |
| July 5, 2007 |
InNexus Appoints Dr. Thomas Kindt, Former National Institute of Health (NIH) Director of Intramural Research, as Chief Scientific Officer, Focuses on Commercialization of DXL™ |
| June 27, 2007 |
Dr. Martin Weigert joins InNexus Biotechnology Scientific Advisory Board |
| June 20, 2007 |
InNexus Named to TSX Venture Top 50 |
| June 12, 2007 |
Dr. Ellen S. Vitetta joins InNexus Biotechnology Scientific Advisory Board |
| June 06, 2007 |
Royalty Pharma and InNexus Biotechnology have completed the previously announced agreement regarding the purchase of royalty rights based on DXL™ antibody products |
| May 29, 2007 |
Dr. Carlos L. Arteaga joins InNexus Biotechnology Scientific Advisory Board |
| May 17, 2007 |
John D. Minna M.D. joins InNexus Biotechnology Scientific Advisory Board |
| May 10, 2007 |
Dr. Thomas Kindt joins InNexus Biotechnology Scientific Advisory Board |
| April 26, 2007 |
Royalty Pharma and InNexus Biotechnology announce agreement regarding the purchase of royalty rights based on DXL™ antibody products |
| April 10, 2007 |
InNexus Biotechnology Announces Appointment of J. Donald Capra, MD, Chairman of Scientific Advisory Board |
| March 6, 2007 |
InNexus Biotechnology Presents at BIO-Europe 2007 |
| February 13, 2007 |
InNexus Biotechnology Appoints Chief Scientific Officer |
| February 8, 2007 |
INNEXUS BIOTECHNOLOGY ANNOUNCES CHANGES TO THE BOARD OF DIRECTORS |
| January 18, 2007 |
INNEXUS BIOTECHNOLOGY ANNOUNCES DEBT SETTLEMENT AGREEMENT |
